हिंदी में पढ़ें
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
MF Returns Calculator
Lupin share price: ICICI Securities downgrades LUPIN to REDUCE, pegs target at Rs 1135
Fri, May 14, 2021
Lupin’s Q4FY21 performance was in-line with ICICI Securities expectations across all parameters. Consolidated revenues declined 1.6% to Rs 37.8 bn with EBITDA margin expanding 500 bps YoY and 70 bps QoQ to 18.7%. US revenue improved 3.7% QoQ to US $195 mn led by traction in Albuterol, despite weak flu season
LUPIN soars 13% on Wednesday, closes at NEW HIGH; Kotak upgrades the stock to BUY with revised Fair Value of Rs 1180
Wed, May 05, 2021
Kotak Institutional Equities says that Lupin is a buying opportunity for the investors and believes scale-up concerns on albuterol post supply disruptions and Sandoz entry are minor. Apart from albuterol, Lupin has multiple growth drivers in place over the medium term including progress on other inhalation assets, filing of biosimilars in the US and potential resolution of warning letters in 2HFY22
Rakesh Jhunjhunwala Stocks: Big Bull makes some changes in portfolio - Do you know the names of these shares held by him?
Wed, Mar 24, 2021
Many investors just think Rakesh Jhunjhunwala is a great investor but few are aware that the Big Bull is an excellent trader as well. In many press conferences, he has explained his trading style. Not only investors admire Jhunjhunwala's investment strategy, the trading community also respects the ace investor for his trading skills as well. Markets are trading at life highs and Big Bull Rakesh Jhunjhunwala has made several changes in his portfolio.
Tech analysis on Big Bull Rakesh Jhunjhunwala stocks: Tata Motors, Titan, Lupin and Escorts
Mon, Mar 01, 2021
Big Bull Rakesh Jhunjhunwala has made several changes in his portfolio. In many interviews, he has explained his trading style and various strategies that traders should follow. Not only investors admire Jhunjhunwala's investment strategy, the trading community also respects. Rakesh Jhunjhunwala stocks that have been in the news are Titan, Tata Motors, Escorts and Lupin.
This Rakesh Jhunjhunwala stocks portfolio is in the news - see strategy
Thu, Feb 25, 2021
Rakesh Jhunjhunwala stocks portfolio has a massive holding in Titan Company. Jhujhunwala holds 5.32% stake in Titan or 4.7 cr shares worth Rs 6850 cr. Titan forms over 42% stake of Rakesh Jhunjhunwala Portfolio. The Big Bull Rakesh Jhunjhunwala holds 1.6% stake in Lupin or 72.45 lk shares in Lupin worth Rs 730 cr.
Big Bull Rakesh Jhunjhunwala stocks: Tata Motors, Titan, Lupin and Escorts
Thu, Feb 18, 2021
Many investors just think Rakesh Jhunjhunwala is a great investor but few are aware he is an excellent trader as well. In many press conferences, he has explained his trading style. Not only investors admire Jhunjhunwala's investment strategy, the trading community also respects the ace investor for his trading skills as well.
Rakesh Jhunjhunwala Stocks - Lupin: How well will it do? Highlights here
Mon, Feb 15, 2021
Ace investor Rakesh Jhunjhunwala holds 72.5 lk shares of Lupin or 1.6% stake in the company. The value of his holding in Lupin is Rs 775 cr. The market cap of Lupin is Rs 48000 cr. The current share price of Lupin is Rs 1060, up Rs 7.5 or 0.7%. Notably, the Big Bull Rakesh Jhunjhunwala had been extremely bullish on Lupin.
Pharma Sector Update: Torrent Pharma, Cipla, Lupin to Alkem Labs - HDFC Securities highlights
Thu, Jan 14, 2021
HDFC Securities see several growth catalysts across key markets and product categories (inhalers, biosimilars, complex injectables) playing out over the next 2-3 years for Indian pharma companies. The investments made over the last few years leave them well placed to capitalise on these opportunities. With cost bases pruned and operating leverage benefits, the sector is poised to grow at 21% earnings CAGR and witness ROCE improvement of 430bps to 15% over FY20- 23e.
CLSA on Cipla, Glenmark, Cadila Healthcare, IPCA Labs and Lupin | What did not work for them and what did
Wed, Dec 16, 2020
CLSA highlights that it was a muted month for pharma companies as November sales disappoint for the Domestic Market. CLSA says it was a strong month for IPCA Labs; gains from integration of acquired brands for Dr Reddy. Falling active cases meant sales of Covid treatment drugs moderated for Glenmark / Cipla (+16%/-24% MoM). Glenmark saw the highest growth in its coverage in November, but excluding these products, its portfolio fell 1% YoY. Cipla’s core growth was a smaller 5.9% YoY.
Stock Market Opening Bell Today: Sensex, Nifty rise on positive global cues; Brigade Enterprises, Dr. Reddy's, Lupin shares gain
Fri, Sep 18, 2020
Stock Market Opening Bell Today: On account of global central banks coming forward to support the COVID-19 hit economy, the Indian stock market opened in the green zone.
Stocks in Focus on September 18: Dr Reddy's, Cipla, Lupin, Happiest Minds Technologies to HDFC Bank; here are expected newsmakers of the day
Fri, Sep 18, 2020
Stocks in Focus on September 18: Dr Reddy's, Cipla, Lupin, Happiest Minds Technologies, HDFC Bank, etc. are expected newsmakers throughout the intraday trade session.
Stocks in Focus on August 7: Banks, HPCL to Jubilant FoodWorks; here are expected newsmakers of the day
Fri, Aug 07, 2020
Stocks in Focus on August 7: HPCL, Jubilant FoodWorks, Pidilite Industries, Adani Enterprises, Torrent Power, etc. are expected newsmakers throughout the intraday trade session.
Stocks in Focus on June 3: ICICI Bank, Britannia Industries, Adani Power to Vedanta; here are expected newsmakers of the day
Wed, Jun 03, 2020
Stocks in Focus on June 3: Britannia Industries, Adani Power, Vedanta, IndiGo, Lupin, etc. are expected newsmakers throughout the intraday trade session.
Stocks in Focus on August 28: Lakshmi Vilas Bank, Yes Bank to GHCL; here are the 5 Newsmakers of the Day
Wed, Aug 28, 2019
Certain stocks came in news post-market hours yesterday and can have an impact on the market when it reopens today.
Buy or Sell: Stock market experts speak on Bajaj Finance, Lupin and Hexaware stocks
Thu, Aug 08, 2019
Stock market experts are advising fresh buy in Bajaj Finance futures while they advise investors to avoid fresh buy in Lupin but one can hold the stock who have this stock in their portfolio. In Hexaware, one can buy the stocks for 4-5 per cent gains.
Lupin, M&M to Tata Steel - Which stocks should you buy?
Thu, Aug 08, 2019
Edelweiss said that Lupin’s current valuation of 17.8x FY21E EPS – amid depressed earnings – offers an attractive entry point in its view.
Stock market tip: Which shares should you invest in?
Fri, Jul 19, 2019
It is very difficult to decide on right stock picks when the market is in the negative territory. When the market is volatile, the investors need to tread very cautiously to gain from the trades. Here are Brokerage Edelweiss' report on these 5 prospective shares:
Lupin recalls over 12,000 cartons of birth control tablets from US market
Sun, Apr 07, 2019
Lupin Pharmaceuticals Inc is recalling 12,464 cartons of the Fayosim (levonorgestrel and ethinyl estradiol) tablets USP, (0.15 mg/0.02 mg, 0.15 mg/0.025 mg, 0.15 mg/0.03 mg)
Rakesh Jhunjhunwala stock Lupin share price 2019 suffers big setback from experts now
Wed, Mar 27, 2019
Rakesh Jhunjhunwala's holding in this stock is valued at above Rs 500 crore and is one of his favourites including Titan, NCC and Escorts.
USFDA classifies Lupin's Somerset facility as 'Official Action Indicated'
Sun, Mar 17, 2019
Drug major Lupin Saturday said it has been cautioned by the US health regulator that its Somerset (New Jersey) facility may be subject to regulatory or administrative action and that it may withhold approval of any pending applications or supplements in which this facility is listed.